EDMUS at ECTRIMS 2005

September 28 - October 1, 2005,
Thessaloniki, Greece

The EDMUS booth

As usual, and thanks to the organiser of the ECTRIMS 2005 Congress Prof. I. MILONAS, the ECTRIMS congress has been a great opportunity to meet the users of the EDMUS system and answer their needs.

An EDMUS booth was held by Dr. Iuliana ACHITI-IONESCU and Dr. Bernard FRANGOULIS in the exhibition hall.

EDMUS 3.4

They were at your disposal for any information regarding the latest version of the software (3.4), presented for the first time on the occasion of ECTRIMS 2005. The software will be ready for final release by February 2006.

 

Thank you to all the EDMUS users and visitors we met in Thessaloniki.

ECTRIMS 2005 web site
EDMUS booth
 

Studies using the EDMUS software

Several oral presentations and posters presented studies using the EDMUS software.

Oral presentations

  • Thursday, September 29, 2005, 10:30 - 12:00
    Parallel Session 2: MS disease evolution
    • (1) Natural course of multiple sclerosis: a unifying concept
      C. Confavreux (Lyon, France)
    • (2) Impact of disease-modifying therapies on long-term disability. An observational study of 1609 relapsing-remitting multiple sclerosis patients: treatment onset before irreversible EDSS 3 delayed disability progression
      E. Le Page, E. Leray, D.A. Laplaud, M. Coustans, J. Chaperon, G. Edan (Rennes, France)
  • Friday, September 30, 2005, 12:15 - 13:30
    European Charcot Foundation Symposium
    • (3) The vaccines in Multiple Sclerosis (VACCIMUS) Study
      C. Confavreux (Lyon, France)

Posters

  • Thursday, September 29, 2005, 15:30 - 17:00
    Poster topic 1: Clinical aspects - diagnosis and differential diagnosis
    • (1) Late onset multiple sclerosis: analysis of the EDMUS database in a French hospital
      S. Mrejen, M. Rosenheim, B. Stankoff, P. Charles, K. Youssov, D. Chabas, A. Tourbah, B. Fontaine, O. Lyon-Caen, C. Lubetzki (Paris, France)
  • Friday, September 30, 2005, 15:30 - 17:00
    Poster topic 15: Epidemiology - Part II
    • (2) Comparison between teaching hospital and population-based data bases
      F. Taithe, C. Cros-Murat, A. Mulliez, D. Aufauvre, M. Lauxerois, P. Clavelou on behalf of the Réseau SEP Auvergne
    • (3) Clinical characteristics of North African and European MS patients in France: greater likelihood of stronger initial course of the disease in African patients
      M. Debouverie, S. Pittion on behalf of the Réseau Lorrain SEP Group
    • (4) Childhood onset multiple sclerosis: the KIDMUS study in European departments of adult neurology
      C. Renoux, S. Vukusic, Y. Mikaeloff, G. Edan, M. Clanet, B. Dubois, M. Debouverie, B. Brochet, C. Lebrun, J. Pelletier, T. Moreau, C. Lubetzki, P. Vermersch, E. Roullet, L. Magy, M. Tardieu, S. Suissa, C. Confavreux for the Kidmus Study Group
    • (5) Impact of disease-modifying therapies on long-term disability. Results of an epidemiological survey of 446 relapsing-remitting MS patients followed for more than 20 years: onset treatments before irreversible EDSS3 delayed disability progression
      D.A. Laplaud, E. Leray, E. Le Page, M. Coustans, J. Chaperon, G. Edan (Rennes, France)